Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OXALIPLATIN vs OXAZEPAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OXALIPLATIN vs OXAZEPAM: Safety Overview

Metric OXALIPLATIN OXAZEPAM
Total FAERS Reports 56,406 12,440
Deaths Reported 6,501 2,965
Death Rate 11.5% 23.8%
Hospitalizations 21,980 6,242
Average Patient Age 61.5 yrs 57.3 yrs
% Female Patients 42.1% 58.3%
FDA Approval Date Apr 28, 2011 Approved Prior to Jan 1, 1982
Manufacturer Camber Pharmaceuticals, Inc. Aphena Pharma Solutions - Tennessee, LLC
Route INTRAVENOUS ORAL
Marketing Status Discontinued Discontinued